Therapy News and Research

RSS

Engineered immune cells attack solid-tumor cancer cells from humans and mice

A method known as CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

30 Jun 2020

Researchers develop potential new therapy for common form of muscular dystrophy

Researchers have designed a potential new treatment for one of the most common forms of muscular dystrophy, according to a new study published today in the Proceedings of the National Academy of Sciences.

29 Jun 2020

Researchers show how upregulation of a single gene by SARs-CoV-2 can trigger cytokine storm

The SARS-CoV-19 virus initially has a limited capability to invade, attacking only one intracellular genetic target, the aryl hydrocarbon receptors (AhRs).

29 Jun 2020

New eye drops could prevent vision loss after retinal vein occlusion

Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.

29 Jun 2020

RCSI begins clinical trial of promising therapy for critically ill COVID-19 patients

Clinician scientists at RCSI University of Medicine and Health Sciences have begun a clinical trial of a promising therapy for critically ill COVID-19 patients in intensive care.

29 Jun 2020

Combination therapy improves survival rates for women with aggressive endometrial cancer

Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.

29 Jun 2020

Innovate UK backs SleepCogni’s pivot to virtual care and remote monitoring

SleepCogni has been awarded a third round of funding from the UK’s innovation agency, Innovate UK in the form of a continuity grant.

29 Jun 2020

New model helps study human hippocampal neurons

Neuroscientists and stem cell researchers at Lund University in Sweden have developed a research model that allows studying human hippocampal neurons, the brain cells primarily affected by Alzheimer's disease pathology.

29 Jun 2020

New polymeric heart valve is a promising alternative for valve replacement surgery, study shows

A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge.

29 Jun 2020

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Antiviral drug screen of kinase inhibitors, which was done by researchers from the University of California and Cedars-Sinai Medical Center, identified cellular signaling pathways critical for SARS-CoV-2 replication and revealed an important mechanism of host-pathogen interaction vital for further drug research. Their results are available on the bioRxiv* preprint server.

28 Jun 2020

Noile-Immune Biotech and C4U team up to develop CRISPR/Cas3 technology

Noile-Immune Biotech Inc., ("Noile-Immune") and C4U Corporation, ("C4U") announced that they have entered into an agreement on joint research and commercialization of next-generation allogeneic gene-modified immune cell therapy combining C4U's CRISPR/Cas3 genome editing technology and Noile-Immune's PRIME (Proliferation inducing and migration enhancing) technology designed to improve proliferation and trafficking of immune cells into solid tumors.

27 Jun 2020

New rapid genomic testing can improve therapy selection for colorectal cancer patients

Genomic mutation testing is critical to therapeutic selection and management of patients with colorectal cancer. In a new multicenter study, researchers compared a new cartridge-based laboratory testing device called the Idylla automated system (Biocartis) to current standard-of-care testing methods.

26 Jun 2020

Physician prescribing of muscle relaxants has tripled from 2005 to 2016, study shows

Office visits for ongoing prescribing of skeletal muscle relaxant drugs tripled from 2005 to 2016, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania.

26 Jun 2020

Less invasive heart treatment now available to all Australians living with aortic stenosis

All Australians living with symptoms of severe aortic stenosis no longer face open heart surgery as the only treatment option, with public access to a less invasive therapy – previously reserved for only the sickest patients – now available to all Australians requiring treatment.

26 Jun 2020

Researchers discover potential new therapy for vascular disorder

Researchers from the Centenary Institute have discovered a potential new therapy for cerebral cavernous malformations, a devastating disease that often affects young people and can result in stroke and seizures.

26 Jun 2020

Vitamin D supplements may help prevent serious side effect of anti-cancer therapy

New research indicates that taking vitamin D supplements may help prevent a potentially serious side effect of a revolutionary form of anti-cancer therapy. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society.

26 Jun 2020

Demand for digital mental health solutions can increase post-pandemic, says GlobalData

Talking therapies for mental health conditions are among countless medical interventions that have been disrupted due to the Covid-19 pandemic.

26 Jun 2020

New radiopharmaceutical shows excellent imaging performance in tumor detection

For neuroendocrine cancer patients with liver metastases, a new radiopharmaceutical, 68Ga-DOTA-JR11, has shown excellent imaging performance in tumor detection, staging, and restaging, providing important information to guide treatment.

26 Jun 2020

Researchers study unique needs of caregivers of persons with ADRD during COVID-19

Sixteen million family members in the U.S. are caregivers for the more than 6 million people living with Alzheimer's Disease and Related Dementias (ADRD).

25 Jun 2020

Pixatimod is active in lab studies against SARS-CoV-2

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) circulating the world has caused over 9.6 million cases and over 490,000 deaths as of June 26, 2020. With neither an effective vaccine nor therapeutic drug yet available, intensive and widespread research is ongoing to develop a pharmacological intervention that will halt the global pandemic.

25 Jun 2020

Therapy News and Research

Engineered immune cells attack solid-tumor cancer cells from humans and mice

Researchers develop potential new therapy for common form of muscular dystrophy

Researchers show how upregulation of a single gene by SARs-CoV-2 can trigger cytokine storm

New eye drops could prevent vision loss after retinal vein occlusion

RCSI begins clinical trial of promising therapy for critically ill COVID-19 patients

Combination therapy improves survival rates for women with aggressive endometrial cancer

Innovate UK backs SleepCogni’s pivot to virtual care and remote monitoring

New model helps study human hippocampal neurons

New polymeric heart valve is a promising alternative for valve replacement surgery, study shows

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Noile-Immune Biotech and C4U team up to develop CRISPR/Cas3 technology

New rapid genomic testing can improve therapy selection for colorectal cancer patients

Physician prescribing of muscle relaxants has tripled from 2005 to 2016, study shows

Less invasive heart treatment now available to all Australians living with aortic stenosis

Researchers discover potential new therapy for vascular disorder

Vitamin D supplements may help prevent serious side effect of anti-cancer therapy

Demand for digital mental health solutions can increase post-pandemic, says GlobalData

New radiopharmaceutical shows excellent imaging performance in tumor detection

Researchers study unique needs of caregivers of persons with ADRD during COVID-19

Pixatimod is active in lab studies against SARS-CoV-2

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News